Data as of Q4 2025 (Dec 31, 2025)

Andera Partners

โ€ขCIK: 1757283โ€ขFiling: Q4 2025

Andera Partners manages $177M across a concentrated portfolio of five positions. The fund exhibits significant conviction, with its largest allocation to BCLYF at $67.4M and MLYS at $57.8M. Further substantial exposure is maintained in EVMN ($32.5M), ABVX ($10.5M), and IVA ($8.5M). This structure suggests a focused, high-conviction approach to generating alpha within its mandate.

Total AUM
$176.6M
QoQ Performance
N/A
Positions
5
Top 10 Concentration
100.0%
Latest Filing
Q4 2025

Top Holdings Allocation

KEST
MLYS
EVMN
ABVX
KESTRA38.1%
MLYS32.7%
EVMN18.4%
ABVX6.0%
IVA4.8%

๐Ÿ“ˆ Biggest Buys

โ€”
KESTRA MED TECHNOLOGIES LTD
NEW
38.1% of portfolio
MLYS
MINERALYS THERAPEUTICS INC
NEW
32.7% of portfolio
EVMN
EVOMMUNE INC
NEW
18.4% of portfolio
ABVX
ABIVAX SA
NEW
6.0% of portfolio
IVA
INVENTIVA SA
NEW
4.8% of portfolio

๐Ÿ“‰ Biggest Sells

No reductions this quarter

Sector Breakdown

Other100.0%